YungShin Global Holding Corporation (3705.TW)
TWD 65.0
(-1.07%)
TWD 65.0
(-1.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.51 Billion TWD | -2.87% |
| 2022 | 11.85 Billion TWD | -1.3% |
| 2021 | 12 Billion TWD | -4.78% |
| 2020 | 12.61 Billion TWD | 2.04% |
| 2019 | 12.35 Billion TWD | 5.05% |
| 2018 | 11.76 Billion TWD | 6.78% |
| 2017 | 11.01 Billion TWD | 8.12% |
| 2016 | 10.19 Billion TWD | 9.99% |
| 2015 | 9.26 Billion TWD | 6.6% |
| 2014 | 8.69 Billion TWD | 5.62% |
| 2013 | 8.22 Billion TWD | 11.24% |
| 2012 | 7.39 Billion TWD | 1.1% |
| 2011 | 7.31 Billion TWD | 6.0% |
| 2010 | 6.9 Billion TWD | 3.78% |
| 2009 | 6.65 Billion TWD | 3.25% |
| 2008 | 6.44 Billion TWD | 0.0% |
| 2006 | 5.82 Billion TWD | 0.06% |
| 2005 | 5.82 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 13.38 Billion TWD | 16.05% |
| 2024 Q1 | 11.53 Billion TWD | 0.17% |
| 2023 Q2 | 11.6 Billion TWD | 1.29% |
| 2023 Q3 | 11.47 Billion TWD | -1.1% |
| 2023 Q1 | 11.45 Billion TWD | -3.34% |
| 2023 Q4 | 11.51 Billion TWD | 0.31% |
| 2023 FY | 11.51 Billion TWD | -2.87% |
| 2022 Q1 | 12.16 Billion TWD | 1.26% |
| 2022 Q4 | 11.85 Billion TWD | 1.62% |
| 2022 Q3 | 11.66 Billion TWD | -3.32% |
| 2022 Q2 | 12.06 Billion TWD | -0.79% |
| 2022 FY | 11.85 Billion TWD | -1.3% |
| 2021 FY | 12 Billion TWD | -4.78% |
| 2021 Q4 | 12 Billion TWD | 0.16% |
| 2021 Q3 | 11.99 Billion TWD | -1.13% |
| 2021 Q2 | 12.12 Billion TWD | 2.58% |
| 2021 Q1 | 11.82 Billion TWD | -6.26% |
| 2020 Q1 | 12.28 Billion TWD | -0.6% |
| 2020 FY | 12.61 Billion TWD | 2.04% |
| 2020 Q2 | 12.35 Billion TWD | 0.57% |
| 2020 Q3 | 12.4 Billion TWD | 0.41% |
| 2020 Q4 | 12.61 Billion TWD | 1.66% |
| 2019 FY | 12.35 Billion TWD | 5.05% |
| 2019 Q2 | 12.21 Billion TWD | 2.63% |
| 2019 Q3 | 12.27 Billion TWD | 0.47% |
| 2019 Q4 | 12.35 Billion TWD | 0.67% |
| 2019 Q1 | 11.9 Billion TWD | 1.2% |
| 2018 Q2 | 11.53 Billion TWD | 2.56% |
| 2018 FY | 11.76 Billion TWD | 6.78% |
| 2018 Q3 | 11.59 Billion TWD | 0.45% |
| 2018 Q4 | 11.76 Billion TWD | 1.5% |
| 2018 Q1 | 11.25 Billion TWD | 2.12% |
| 2017 Q3 | 10.82 Billion TWD | 0.71% |
| 2017 Q2 | 10.74 Billion TWD | 3.47% |
| 2017 Q1 | 10.38 Billion TWD | 1.93% |
| 2017 FY | 11.01 Billion TWD | 8.12% |
| 2017 Q4 | 11.01 Billion TWD | 1.79% |
| 2016 FY | 10.19 Billion TWD | 9.99% |
| 2016 Q2 | 10.55 Billion TWD | 11.81% |
| 2016 Q4 | 10.19 Billion TWD | 0.96% |
| 2016 Q1 | 9.44 Billion TWD | 1.93% |
| 2016 Q3 | 10.09 Billion TWD | -4.41% |
| 2015 Q3 | 8.92 Billion TWD | -3.35% |
| 2015 FY | 9.26 Billion TWD | 6.6% |
| 2015 Q4 | 9.26 Billion TWD | 3.82% |
| 2015 Q2 | 9.23 Billion TWD | 3.3% |
| 2015 Q1 | 8.93 Billion TWD | 2.84% |
| 2014 Q3 | 8.29 Billion TWD | -3.71% |
| 2014 Q2 | 8.61 Billion TWD | 1.79% |
| 2014 Q1 | 8.46 Billion TWD | 2.83% |
| 2014 FY | 8.69 Billion TWD | 5.62% |
| 2014 Q4 | 8.69 Billion TWD | 4.8% |
| 2013 Q1 | 7.63 Billion TWD | 3.2% |
| 2013 Q2 | 7.93 Billion TWD | 3.92% |
| 2013 Q4 | 8.22 Billion TWD | 4.24% |
| 2013 Q3 | 7.89 Billion TWD | -0.49% |
| 2013 FY | 8.22 Billion TWD | 11.24% |
| 2012 Q2 | 7.67 Billion TWD | 5.2% |
| 2012 Q3 | 7.25 Billion TWD | -5.47% |
| 2012 Q4 | 7.39 Billion TWD | 2.0% |
| 2012 FY | 7.39 Billion TWD | 1.1% |
| 2012 Q1 | 7.29 Billion TWD | -0.34% |
| 2011 Q3 | 7.09 Billion TWD | -4.57% |
| 2011 FY | 7.31 Billion TWD | 6.0% |
| 2011 Q1 | 5.6 Billion TWD | -18.84% |
| 2011 Q2 | 7.43 Billion TWD | 32.71% |
| 2011 Q4 | 7.31 Billion TWD | 3.13% |
| 2010 FY | 6.9 Billion TWD | 3.78% |
| 2010 Q4 | 6.9 Billion TWD | 0.0% |
| 2009 FY | 6.65 Billion TWD | 3.25% |
| 2008 FY | 6.44 Billion TWD | 0.0% |
| 2006 FY | 5.82 Billion TWD | 0.06% |
| 2005 FY | 5.82 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Grape King Bio Ltd | 15.51 Billion TWD | 25.783% |
| Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -2.893% |
| Maywufa Company Ltd. | 2.83 Billion TWD | -306.502% |
| ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | 1.784% |
| Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 65.105% |
| LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -1280.101% |
| PhytoHealth Corporation | 2.35 Billion TWD | -389.784% |
| SCI Pharmtech, Inc. | 6.69 Billion TWD | -72.065% |
| Formosa Laboratories, Inc. | 13.63 Billion TWD | 15.574% |
| PharmaEssentia Corporation | 27.26 Billion TWD | 57.782% |
| Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | 54.046% |